DIM — Sartorius Stedim Biotech SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual balance sheet for Sartorius Stedim Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	237	133	133	691	450
Net Total Accounts Receivable
Net Total Receivables	371	419	334	300	224
Total Inventory
Total Other Current Assets
Total Current Assets	1,456	1,671	1,415	1,741	1,441
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	928	1,292	1,633	1,885	2,025
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,951	5,065	7,730	8,256	7,984
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,037	1,036	937	939	1,412
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,295	2,616	5,092	4,270	3,893
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,656	2,449	2,639	3,987	4,091
Total Liabilities & Shareholders' Equity	3,951	5,065	7,730	8,256	7,984
Total Common Shares Outstanding